Literature DB >> 24746934

Optimal timing of pulmonary metastasectomy--is a delayed operation beneficial or counterproductive?

M Krüger1, J D Schmitto2, B Wiegmann2, T K Rajab3, A Haverich2.   

Abstract

INTRODUCTION: Pulmonary metastasectomy represents an established approach in the treatment of lung metastases related to several solid malignant tumors, promising the chance of long term survival. Regarding the proper timing of metastasectomy both operation promptly after diagnosis and delayed operation after an interval of 3 months are common practice.
MATERIALS AND METHODS: A systematic Medline search addressing the optimal timing of metastasectomy was performed. Since the search query "timing of metastasectomy" yields only a limited number of articles, the Medline search was expanded to include the main arguments for prompt metastasectomy ("metastases of metastasis", "growth rate of pulmonary metastases") and for delayed metastasectomy.
RESULTS: Based on the data available to date, there is no necessity to expedite the timing of the operation. On the other hand, there is no evidence that a delayed operation, for example after re-staging following an interval of 3 months, provides a benefit.
CONCLUSION: Therefore the timing of metastasectomy should only depend on the patient's requirements, such as general state of health and oncologic considerations, such as promising multimodal therapy concepts, extrathoracal tumor manifestations or oncologic type of the primary tumor. A delayed operation seems justified if the indication for resection is questionable due to a high risk of early multilocal recurrence.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Metastasectomy; Pulmonary metastases; Timing

Mesh:

Year:  2014        PMID: 24746934     DOI: 10.1016/j.ejso.2014.03.017

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

Review 1.  Past, present, and future perspectives of pulmonary metastasectomy for patients with advanced colorectal cancer.

Authors:  Tomohiro Murakawa
Journal:  Surg Today       Date:  2020-08-28       Impact factor: 2.549

Review 2.  Management of Sarcoma Metastases to the Lung.

Authors:  Christopher S Digesu; Ory Wiesel; Ara A Vaporciyan; Yolonda L Colson
Journal:  Surg Oncol Clin N Am       Date:  2016-10       Impact factor: 3.495

Review 3.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

Review 4.  Survival and prognostic factors following pulmonary metastasectomy for sarcoma.

Authors:  Giuseppe Marulli; Marco Mammana; Giovanni Comacchio; Federico Rea
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

5.  The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas.

Authors:  Hiromasa Yamamoto; Kei Namba; Haruchika Yamamoto; Tomohiro Toji; Junichi Soh; Kazuhiko Shien; Ken Suzawa; Takeshi Kurosaki; Shinji Otani; Mikio Okazaki; Seiichiro Sugimoto; Masaomi Yamane; Katsuhito Takahashi; Toshiyuki Kunisada; Takahiro Oto; Shinichi Toyooka
Journal:  Surg Today       Date:  2020-08-03       Impact factor: 2.549

6.  Increased lymphangiogenesis in lung metastases from colorectal cancer is associated with early lymph node recurrence and decreased overall survival.

Authors:  Thomas Schweiger; Christoph Nikolowsky; Thomas Graeter; Gernot Seebacher; Jürgen Laufer; Olaf Glueck; Christoph Glogner; Peter Birner; György Lang; Walter Klepetko; Hendrik Jan Ankersmit; Konrad Hoetzenecker
Journal:  Clin Exp Metastasis       Date:  2015-10-23       Impact factor: 5.150

7.  Pulmonary metastasectomy: a cross sectional survey.

Authors:  James M Caristo; David H Tian; Tristan D Yan
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

8.  The predictive accuracy of sentinel nodes mapping in the setting of pulmonary metastasectomy.

Authors:  Hyun Koo Kim; Kwanghyoung Lee; Kook Nam Han; Jae Seon Eo; Sungeun Kim; Young Ho Choi
Journal:  Clin Exp Metastasis       Date:  2017-01-06       Impact factor: 5.150

9.  Outcomes of surgical resection for pulmonary metastasis from ovarian cancer.

Authors:  Ryu Kanzaki; Jiro Okami; Koji Takami; Teruo Iwasaki; Naoki Ikeda; Yasunobu Funakoshi; Yasushi Sakamaki; Ken Kodama; Hideoki Yokouchi; Yoshihisa Kadota; Naoko Ose; Yasushi Shintani
Journal:  J Cardiothorac Surg       Date:  2020-07-23       Impact factor: 1.637

10.  Survival after pulmonary metastasectomy in colorectal cancer patients: does a history of resected liver metastases worsen the prognosis? A literature review.

Authors:  Jon Zabaleta; Borja Aguinagalde; Iker Lopez; Arantza Fernandez-Monge; Jose M Izquierdo; Jose I Emparanza
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.